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Retiform hemangioendothelioma (RHE) is a rare vascular neoplasm of an intermediate grade of malignancy. It was first described by Calonje et al. in 1994 [1]. HE usually 
occurs in the age group of 20–80 years, and approximately 25% 
are multicentric [2]. These tumors commonly involve the lower 
limb bones; however, <10% also involve vertebrae and only few 
may occur in the skull, pelvis, and clavicle [2,3]. These tumors 
have a high rate of local recurrence and low rate of metastasis. 
Two studies on RHE have been described, one by Aditya et al. [4] 
who reported RHE as a primary bone tumor arising from parietal 
bone and the other by Kyo Kim et al. [5] arising from the sphenoid 
bone in infratemporal fossa.
We report an unusual case of multifocal RHE, mimicking 
metastasis clinically as well as radiologically, and extensive 
literature search has failed to reveal such presentation of RHE as 
a primary bone tumor.
CASE REPORT
A 38-year-old male presented to the department with a chief 
complaint of difficulty in lifting the left upper limb above the 
shoulder level and decrease in power or feeling of weakness in 
the same for 6 months. He gave a history of a fall while practicing 
martial arts in August 2016. The physical examination revealed 
no abnormality except tenderness while lifting the left upper 
limb. The vitals were within the normal range.
The radiographic investigation (X-ray) showed complete 
destruction of the left glenohumeral joint with an irregularly 
marginated destruction of the glenoid cavity of the left scapula. 
Adjacent lobulated homogenous soft tissue density was noted in 
the left axilla, which was suggestive of a malignant lesion. Cortical 
breech along with radiolucent areas in the medulla was noted in 
the left proximal humerus. Subsequent non-contrast-enhanced 
computerized tomography (NCCT) and magnetic resonance 
imaging (MRI) revealed expansile soft tissue mass involving the 
glenoid cavity. The adjacent body of the left scapula was causing 
a destruction of the same with extension into adjacent soft tissue, 
and associated lytic changes were seen in the left proximal 
humerus and proximal end of ulna (Fig. 1).  A fluorodeoxyglucose-
positron emission tomography scan showed these lesions to be 
metabolically active and destructive. Based on the above findings, 
a possibility of skeletal metastasis was given. Incision biopsy from 
the left elbow showed marked capillary proliferation admixed 
with lymphocytic infiltrate and eosinophils. The possibility of a 
vasoformative lesion was suggested.
The patient underwent the left upper limb forequarter amputation 
removing the whole of the scapula, part of the clavicle, and the 
whole upper limb. Gross examination (Fig. 2) revealed hemorrhagic 
destructive lesion involving the glenoid cavity and adjacent body of 
the scapula with extension into adjacent soft tissue. Hemorrhagic 
lytic lesions were also noted in the proximal humerus (Fig. 2) 
and proximal end of the ulnar olecranon process. Microscopic 
examination of sections from scapula, humerus, and olecranon 
process revealed similar morphology with a presence of an irregular 
pattern of the elongated and arborizing vessels. Neoplastic vessels 
were lined by a single layer of hobnail-like endothelial cells along 
with the presence of papillae having a hyalinized collagenous core. 
The intervening stroma was fibrotic and showed lymphocytic and 
eosinophilic inflammatory infiltrate (Fig. 3). The tumor cells lacked 
cytological atypia, and mitosis was sparse. The final diagnosis of 
RHE was given. Unfortunately, the patient was lost to follow-up. 
Hence, no additional therapy or treatment was given to the patient.
ABSTRACT
Hemangioendothelioma (HE) is a rare primary bone tumor of vascular origin constituting 0.5–1% of primary malignant bone 
tumors. Here, we report the clinical and histopathological features of a 38-year-old male who presented with multifocal lesions 
involving the left scapula, left proximal humerus, and the left ulnar olecranon process which was diagnosed as metastatic lesion 
radiologically and clinically. The final diagnosis of retiform HE was made on the basis of histopathology.
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DISCUSSION
Vascular tumors of bone are a heterogeneous group having 
different classification schemes. These tumors in bone arise 
from endothelial cells, resulting in variable expression of 
endothelial markers which cannot differentiate between 
benign and malignant lesions [6]. The classification of 
vascular tumors of bone is controversial due to the lack of 
consistent terminology, definitive histologic criteria, and 
limited correlation with clinical outcome [6]. In 2000, Wenger 
and Wold proposed a new classification system for benign 
and malignant vascular tumors, considering these lesions as a 
spectrum [6] (Table 1).
HE can affect any portion of the skeleton but most 
commonly involves the axial skeleton. They have slight male 
preponderance with multicentricity described in 25% of 
cases [2]. Histopathological examination is required to confirm 
the diagnosis of RHE as it does not have definitive clinical or 
radiologic features. The radiological appearance of vascular 
tumors is not specific; however, radiologic multifocality points 
toward vascular neoplasm as a differential possibility [6,7]. 
Radiologically, malignant vascular tumors of the bone present 
as single or multiple (contiguous/disseminated) lytic lesions 
with cortical destruction and endosteal scalloping or have 
mixed sclerotic and lytic pattern [6]. The possible differential 
diagnosis to be considered in young and old patients presenting 
with multifocal lytic lesions and with mixed pattern has been 
summarized in Table 2 [2,8].
Requena and Kutzner [9] described seven subtypes of HE, 
RHE, spindle cell HE (hemangioma), papillary intralymphatic 
angioendothelioma (Dabska tumor), Kaposiform HE, 
epithelioid HE, pseudomyogenic HE, and composite HE. The 
biological behavior of these vascular tumors is intermediate 
Figure 1: Magnetic resonance imaging. (a) Axial T2 image shows 
a lytic expansive lesion with multiple flow voids in the scapula. 
(b) Sagittal PD image showing hyperintense lytic lesion in proximal 
humerus in the same patient
a b
Figure 2: Gross examination. (a)  Hemorrhagic destructive lesion 
involving glenoid cavity and adjacent body of the scapula with 
extension into adjacent soft tissue (b) Hemorrhagic lytic lesions 
noted in the proximal humerus
a b
Table 1: Proposed classification of vascular tumors of the bone by 
Wenger and Wold (2000)
Proposed classification of vascular tumors of the bone
Benign vascular tumors of the bone
Hemangioma
Cavernous
Capillary
(Hem) angiomatosis
Non-aggressive, regional
Non-aggressive, disseminated (cystic angiomatosis)
Aggressive or massive osteolysis or Gorham stout’s disease
Intermediate (locally aggressive and rarely metastasizing) 
vascular tumors of bone Epithelioid hemangioma
Malignant vascular tumors of the bone
Epithelioid hemangioendothelioma
Angiosarcoma
Primary
Irradiation-induced
Bone infarction associated
Table 2: Differential diagnosis of multifocal retiform 
hemangioendothelioma of bone
Purely lytic 
pattern
Young Histiocytosis
Brown tumor
Metastasis
Old Metastasis
Myeloma
Lymphoma
Mixed lytic and 
sclerotic pattern
Solitary lesion 
with well-defined 
margins
Fibrous dysplasia
Aneurysmal bone cyst
Fibrous cortical defect
Solitary lesion 
with ill-defined 
margins
Osteosarcoma
Ewing’s sarcoma
Fibrosarcoma
Figure 3: Microscopic examination. (a) Characteristic narrow and 
arborizing vascular channel infiltrating bone (H & E ×40). (b) The 
intervening fibrotic stroma showed lymphocytic and eosinophilic 
inflammatory infiltrate. (c) Neoplastic vessels lined by a single layer 
of hobnail-like endothelial cells along with papillae having hyalinized 
collagenous cores
a b
c
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between benign hemangioma and malignant angiosarcoma. All 
cases of spindle cell HE showed benign behavior and hence 
were categorized as a hemangioma. Epithelioid HE had more 
aggressive biological behavior than the other subtypes. The 
other five subtypes including RHE are truly borderline vascular 
lesions.
HE has been classified into three histologic grades (Grade 1, 
2, and 3) based on the degree of vasoformative appearance, 
tumor cell pleomorphism, and mitotic figures. This grading was 
described by Unni [10]. The grade of anaplasia is considered as the 
most important indicator of prognosis with disease-free survival 
decreasing with increasing grade [8,10]. The final diagnosis of 
RHE is usually available postoperatively as the pre-operative 
biopsy may not give a definitive diagnosis as in our case. The 
need for surgical intervention and post-operative adjuvant therapy 
(chemotherapy/radiotherapy) should be carefully considered to 
avoid unnecessary complications, but no post adjuvant therapy 
was administered in the present case as the patient was lost to 
follow up.
CONCLUSION
RHE is a rare vascular neoplasm of an intermediate grade of 
malignancy. A number of diagnostic techniques are available, 
but final diagnosis of such lesion can be done on the basis of 
histopathology. Surgery and post-operative adjuvant therapy 
(chemotherapy/radiotherapy) can be used as a treatment modality. 
The improved prognosis of patients depends on the early diagnosis 
and accurate treatment.
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